Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Individualized treatments may help manage Dercum's disease symptoms.

Soluble CD83 speeds up wound healing and reduces scarring.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Treating cystoid macular oedema in uveitis is difficult and risky.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Rituximab may cause skin issues, but baricitinib can help improve them.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Rituximab can cause skin issues, but baricitinib may help improve them.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

CTP-543 is generally safe for treating alopecia areata.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

An arthritis drug helped a person with severe hair loss regrow their hair.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Glucocorticoid treatment improved symptoms in a girl with Satoyoshi disease.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Baricitinib shows promise in treating severe hair loss.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.